首页 | 本学科首页   官方微博 | 高级检索  
     


Rapid Discovery of Aspartyl Protease Inhibitors Using an Anchoring Approach
Authors:Dr. Markella Konstantinidou  Francesca Magari  Fandi Sutanto  Dr. Jörg Haupenthal  Dr. Varsha R. Jumde  Dr. M. Yagiz Ünver  Prof. Dr. Andreas Heine  Dr. Carlos Jamie Camacho  Prof. Dr. Anna K. H. Hirsch  Prof. Dr. Gerhard Klebe  Prof. Dr. Alexander Dömling
Affiliation:1. Department of Pharmacy Drug Design Group, University of Groningen, A. Deusinglaan 1, 9713 AV Groningen, The Netherlands;2. Institute of Pharmaceutical Chemistry, Philipps University Marburg, Marbacher Weg 6, 35032 Marburg, Germany;3. Department of Drug Design and Optimization Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), Helmholtz Centre for Infection Research (HZI), Campus E8.1, 66123 Saarbrücken, Germany;4. Department of Drug Design and Optimization Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), Helmholtz Centre for Infection Research (HZI), Campus E8.1, 66123 Saarbrücken, Germany

Stratingh Institute for Chemistry, University of Groningen, Nijenborgh 7, 9747 AG Groningen, The Netherlands;5. Department of Computational and Systems Biology, University of Pittsburgh, 3501 Fifth Avenue, Pittsburgh, PA 15260 USA;6. Department of Drug Design and Optimization Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), Helmholtz Centre for Infection Research (HZI), Campus E8.1, 66123 Saarbrücken, Germany

Stratingh Institute for Chemistry, University of Groningen, Nijenborgh 7, 9747 AG Groningen, The Netherlands

Department of Pharmacy, Saarland University, Campus E8.1, 66123 Saarbrücken, Germany

Abstract:Pharmacophore searches that include anchors, fragments contributing above average to receptor binding, combined with one-step syntheses are a powerful approach for the fast discovery of novel bioactive molecules. Here, we are presenting a pipeline for the rapid and efficient discovery of aspartyl protease inhibitors. First, we hypothesized that hydrazine could be a multi-valent warhead to interact with the active site Asp carboxylic acids. We incorporated the hydrazine anchor in a multicomponent reaction and created a large virtual library of hydrazine derivatives synthetically accessible in one-step. Next, we performed anchor-based pharmacophore screening of the libraries and resynthesized top-ranked compounds. The inhibitory potency of the molecules was finally assessed by an enzyme activity assay and the binding mode confirmed by several soaked crystal structures supporting the validity of the hypothesis and approach. The herein reported pipeline of tools will be of general value for the rapid generation of receptor binders beyond Asp proteases.
Keywords:hydrazine-tetrazoles  MCR chemistry  docking protocol  aspartic protease  crystal structures
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号